Free Trial

WAVE Life Sciences (WVE) Competitors

WAVE Life Sciences logo
$8.40 +0.01 (+0.12%)
Closing price 04:00 PM Eastern
Extended Trading
$8.40 0.00 (-0.01%)
As of 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WVE vs. LNTH, PCVX, MTSR, CYTK, MRUS, AKRO, KRYS, RNA, SRRK, and ADMA

Should you be buying WAVE Life Sciences stock or one of its competitors? The main competitors of WAVE Life Sciences include Lantheus (LNTH), Vaxcyte (PCVX), Metsera (MTSR), Cytokinetics (CYTK), Merus (MRUS), Akero Therapeutics (AKRO), Krystal Biotech (KRYS), Avidity Biosciences (RNA), Scholar Rock (SRRK), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry.

WAVE Life Sciences vs. Its Competitors

WAVE Life Sciences (NASDAQ:WVE) and Lantheus (NASDAQ:LNTH) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

WAVE Life Sciences currently has a consensus price target of $20.15, indicating a potential upside of 139.93%. Lantheus has a consensus price target of $131.20, indicating a potential upside of 79.90%. Given WAVE Life Sciences' stronger consensus rating and higher possible upside, analysts plainly believe WAVE Life Sciences is more favorable than Lantheus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WAVE Life Sciences
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.92
Lantheus
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Lantheus has higher revenue and earnings than WAVE Life Sciences. WAVE Life Sciences is trading at a lower price-to-earnings ratio than Lantheus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WAVE Life Sciences$108.30M12.07-$97.01M-$0.84-10.00
Lantheus$1.53B3.29$312.44M$3.5220.72

WAVE Life Sciences has a beta of -1.01, indicating that its share price is 201% less volatile than the S&P 500. Comparatively, Lantheus has a beta of 0.12, indicating that its share price is 88% less volatile than the S&P 500.

Lantheus has a net margin of 16.55% compared to WAVE Life Sciences' net margin of 0.00%. Lantheus' return on equity of 36.99% beat WAVE Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
WAVE Life SciencesN/A -86.49% -37.20%
Lantheus 16.55%36.99%20.55%

89.7% of WAVE Life Sciences shares are held by institutional investors. Comparatively, 99.1% of Lantheus shares are held by institutional investors. 24.0% of WAVE Life Sciences shares are held by insiders. Comparatively, 1.5% of Lantheus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Lantheus had 8 more articles in the media than WAVE Life Sciences. MarketBeat recorded 14 mentions for Lantheus and 6 mentions for WAVE Life Sciences. Lantheus' average media sentiment score of 1.22 beat WAVE Life Sciences' score of 1.15 indicating that Lantheus is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
WAVE Life Sciences
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Lantheus
9 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Lantheus beats WAVE Life Sciences on 11 of the 16 factors compared between the two stocks.

Get WAVE Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WVE vs. The Competition

MetricWAVE Life SciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.31B$3.07B$5.70B$9.51B
Dividend YieldN/A2.36%4.69%4.01%
P/E Ratio-10.0021.0428.0720.05
Price / Sales12.07284.46448.5799.42
Price / CashN/A42.7636.2258.56
Price / Book6.138.378.665.87
Net Income-$97.01M-$55.19M$3.25B$258.55M
7 Day Performance0.72%5.89%4.20%2.23%
1 Month Performance22.63%17.63%10.82%12.76%
1 Year Performance33.33%5.09%34.70%19.36%

WAVE Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WVE
WAVE Life Sciences
4.5555 of 5 stars
$8.40
+0.1%
$20.15
+139.9%
+36.4%$1.31B$108.30M-10.00240Positive News
Upcoming Earnings
LNTH
Lantheus
4.7027 of 5 stars
$72.17
-1.9%
$131.20
+81.8%
-37.6%$4.99B$1.53B20.50700Positive News
PCVX
Vaxcyte
1.8172 of 5 stars
$36.85
-1.4%
$136.50
+270.5%
-57.4%$4.76BN/A-9.25160News Coverage
Positive News
MTSR
Metsera
N/A$44.64
+0.8%
$55.00
+23.2%
N/A$4.69BN/A0.0081Lockup Expiration
Gap Up
CYTK
Cytokinetics
4.2246 of 5 stars
$38.09
-2.1%
$70.92
+86.2%
-34.3%$4.55B$18.47M-7.20250News Coverage
MRUS
Merus
1.9956 of 5 stars
$63.32
+3.1%
$84.64
+33.7%
+20.1%$4.38B$36.13M-15.5237Upcoming Earnings
AKRO
Akero Therapeutics
3.7809 of 5 stars
$54.23
-0.2%
$82.50
+52.1%
+88.3%$4.32BN/A-27.8130Positive News
KRYS
Krystal Biotech
4.8886 of 5 stars
$149.11
-0.7%
$213.75
+43.4%
-27.4%$4.30B$290.52M35.80210News Coverage
Analyst Forecast
RNA
Avidity Biosciences
2.1576 of 5 stars
$35.10
+3.1%
$66.35
+89.0%
-25.6%$4.23B$10.90M-11.69190News Coverage
SRRK
Scholar Rock
3.2631 of 5 stars
$43.21
+0.8%
$42.67
-1.2%
+342.4%$4.10B$33.19M-17.08140
ADMA
ADMA Biologics
3.6093 of 5 stars
$17.04
-3.2%
$27.67
+62.4%
+27.5%$4.07B$426.45M20.08530News Coverage

Related Companies and Tools


This page (NASDAQ:WVE) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners